CLOSE X

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE5638.35-119.15 (-2.07 %)
PREV CLOSE ( ) 5757.50
OPEN PRICE ( ) 5757.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20847
TODAY'S LOW / HIGH ( )5592.70 5795.75
52 WK LOW / HIGH ( )3640.1 6448.75
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 12-10 1990
Management Info
Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director
Registered Office

Address 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone 040 66966300 / 400

Email mail@divislabs.com

Website www.divislabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
31Mar Divi's Laboratories informs about cess
Divi's Laboratories has informed that G. Bala Kishore, serving as Genera..
31Mar Divis Laboratories informs about tradi
Divis Laboratories has informed that the Trading Window for dealing in s..
21Feb Divi's Laboratories informs about disc
Divi's Laboratories has informed that the exchange has received the disc..
03Feb Divi's Laboratories informs about inte
Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated..
02Jan Divi's Laboratories starts commercial
Divi's Laboratories has commenced commercial operations from a part of t..
Financials
Rs. in Millions
QTR Dec 24 ANNUAL 24
Net Profit594015760
Gross Profit 7300 21320
Operating Profit 829025110
Net Sales 2297076650
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 8749.25 (2.80%)
M.Cap ( in Cr)21873.13
SMS Lifesciences (BSE)
 1431.30 (12.48%)
M.Cap ( in Cr)432.72
Emcure Pharma (BSE)
 1094.65 (9.13%)
M.Cap ( in Cr)20741.79
Neuland Laboratories (BSE)
 12824.35 (0.65%)
M.Cap ( in Cr)16453.50
Ajanta Pharma (BSE)
 2695.10 (2.28%)
M.Cap ( in Cr)33665.06
Shareholding Pattern
PROMOTERS 51.89%
MUTUAL FUNDS/UTI 11.89%
NON-INSTITUTION 9.59%
FI/BANKS/INSURANCE 7.73%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data January 2025 Broking Complaints Data January 2025 PMS Complaints Data January 2025 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.